HealthQuill hypertension
Swedish-British AstraZeneca Plc’s medicine baxdrostat lowered blood pressure in trial patients during an end-stage study, and the company plans to file for regulatory approvals by the end of the year.
Drugs Health Pharma

AstraZeneca’s medicine lowers BP, to file for early approvals

Swedish-British AstraZeneca Plc’s medicine baxdrostat lowered blood pressure in trial patients during an end-stage study, and the company plans to file for regulatory.

Read More
Novo Nordisk’s medicine Wegovy, at a higher dose, resulted in an average weight loss of 21% during trials in people with obesity compared to a dummy drug, the company stated.
Drugs Health Pharma

Wegovy’s weight-loss efficacy improves with higher dosage

HQ Team June 21, 2025: Novo Nordisk’s medicine Wegovy, at a higher dose, resulted in an average weight loss of 21% during trials.

Read More
Researchers have found genomic variants in one-third of people from the West African countries of Ghana and Nigeria that significantly increase the risk of developing kidney diseases.
Drugs Health Medical

One-third of West Africans have gene variants causing kidney disease

Researchers have found genomic variants in one-third of people from the West African countries of Ghana and Nigeria that significantly increase the risk.

Read More
Lowering sodium intake can reduce blood pressure regardless of whether one is on medication, a study reveals.
Climate Health Medical

Hype and disputes surrounding blood pressure measurement

HQ Team October 17, 2024: Blood pressure measurement is a critical procedure in diagnosing and managing hypertension, yet it is fraught with scientific.

Read More
Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia, projected to affect 153 million people by 2050.
Drugs Health Pharma

Untreated vision loss, high LDL cholesterol risk factors for dementia

Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,.

Read More
June 27, 2024: Novo Nordisk’s end-stage trial for hypertension drug has failed to meet its primary goal and the Danish multinational has recognised an impairment loss of 5.7 Danish crowns or $817 million in the second quarter of this year.
Drugs Health Pharma

Novo’s end-stage hypertension trial drug fails, $817m impairment loss

Novo Nordisk’s end-stage trial for hypertension drug has failed to meet its primary goal and the Danish multinational has recognised an impairment loss.

Read More
The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to treat pulmonary arterial hypertension.
Drugs Health Pharma

US regulator clears Merck’s lung therapy after ‘significant’ results

 HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to.

Read More
Lowering sodium intake can reduce blood pressure regardless of whether one is on medication, a study reveals.
Drugs Health Medical

Salt substitutes effective in reducing hypertension in elderly people

HQ Team February 13, 2024: Adding to the long line of evidence that reducing salt intake affects blood pressure is the latest study.

Read More
Otsuka Medical Devices Co., announced its treatment for hypertension has got approval from the US Food and Drug Administration.
Health Medical Pharma

Otsuka Medical gets USFDA nod for treatment of hypertension  

Otsuka Medical Devices Co., announced its treatment for hypertension has got approval from the US Food and Drug Administration.

Read More
Drugs Health Pharma

Novo Nordisk to buy hypertension drug from KBP for $1.3 billion

HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP.

Read More